Finance

Beta
Lists
Q3 2026 earnings • released • EPS beat +11.14% • Revenue beat +1.90%
See results
LOVE:TSE
Cannara Biotech Inc
CA$1.92
0.00%
(0.00) 1D
Jul 17, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for LOVE...
Open
CA$1.93
High
CA$1.94
Low
CA$1.90
Mkt. cap
189.66M
Avg. vol.
48.24K
Volume
21.90K
P/E ratio
17.79
52-wk high
CA$2.07
52-wk low
CA$1.55
EPS
CA$0.11
Beta
0.34
Shares outstanding
98.78M
No. of employees
452
Open
CA$1.93
High
CA$1.94
Low
CA$1.90
Mkt. cap
189.66M
Avg. vol.
48.24K
Volume
21.90K
P/E ratio
17.79
52-wk high
CA$2.07
52-wk low
CA$1.55
EPS
CA$0.11
Beta
0.34
Shares outstanding
98.78M
No. of employees
452
News stories
From sources across the web
About Cannara Biotech Inc
CEO-
Employees452
Founded2017
Headquarters-
SectorPersonal care products
Websitecannara.ca
Last report
Jul 15, 2026
Fiscal period
Q3 2026
EPS / Est. (CAD)
CA$0.04 / CA$0.04
+11.14%beat
Revenue / Est. (CAD)
31.83M / 31.23M
+1.90%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
28.52M
30.11M
27.15M
31.83M
Cost of goods sold
16.13M
18.90M
15.53M
16.80M
Cost of revenue
16.13M
18.90M
15.53M
16.80M
Research and development expenses
191.15K
287.45K
400.70K
344.72K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.02M
6.23M
6.50M
6.30M
Operating expense
7.30M
8.51M
8.25M
7.67M
Total operating expenses
23.43M
27.41M
23.78M
24.47M
Operating income
5.09M
2.70M
3.37M
7.36M
Other non operating income
-379.12K
-73.54K
-93.55K
-
EBT including unusual items
4.54M
2.04M
2.82M
6.87M
EBT excluding unusual items
4.00M
2.04M
2.94M
6.87M
Income tax expense
1.23M
1.00M
1.16M
2.03M
Effective tax rate
27.03%
49.07%
41.04%
29.54%
Other operating expenses
-
-
-
-
Net income
3.31M
1.04M
1.66M
4.84M
Net profit margin
11.62%
3.45%
6.12%
15.21%
Earnings per share
-
-
0.02
0.04
Interest and investment income
89.58K
82.70K
84.27K
-
Interest expense
-805.27K
-608.11K
-465.53K
-485.08K
Net interest expenses
-715.69K
-525.41K
-381.26K
-485.08K
Depreciation and amortization charges
-
266.74K
252.99K
238.30K
EBITDA
7.26M
4.22M
4.61M
8.93M
Gain or loss from assets sale
-422.17K
-
122.01K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer